BYSI

MKT CAP:$72M

BeyondSpring Inc

Market Cap

$72M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$1.71+$0.10 (+6.21%)

Jun 5, 2026

52W High $3.4052W Low $1.27

Company Details

BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on developing and selling clinical-stage biopharmaceutical therapies focused on oncology and immunology. The company operates through two segments: the Plinabulin pipeli...

CEO

—

IPO Date

Mar 9, 2017

Website

beyondspringpharma.com

Key Metrics TTM

Revenue

+100.0% YoY

Net Income

-$8M

EPS (Diluted)

Free Cash Flow

-$19M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

May 13, 2026

FY 2025

Mar 25, 2026

Q4 2025

Mar 25, 2026

$0+100.0%

Q3 2025

Nov 12, 2025

$0+100.0%

Q2 2025

Aug 13, 2025

$0-100.0%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee